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DOI: 10.1039/c1jm10329fA synthetic method to prepare novel multifunctional core-shell-structured mesoporous silica
nanoparticles for simultaneous magnetic resonance (MR) and fluorescence imaging, cell targeting and
photosensitization treatment has been developed. Superparamagnetic magnetite nanoparticles and
fluorescent dyes are co-encapsulated inside nonporous silica nanoparticles as the core to provide dual-
imaging capabilities (MR and optical). The photosensitizer molecules, tetra-substituted carboxyl
aluminum phthalocyanine (AlC4Pc), are covalently linked to the mesoporous silica shell and exhibit
excellent photo-oxidation efficiency. The surface modification of the core-shell silica nanoparticles with
folic acid enhances the delivery of photosensitizers to the targeting cancer cells that overexpress the
folate receptor, and thereby decreases their toxicity to the surrounding normal tissues. These unique
advantages make the prepared multifunctional core-shell silica nanoparticles promising for cancer
diagnosis and therapy.1. Introduction
Photodynamic therapy (PDT) is now well established as a tech-
nique for cancer treatment.1–3 Typically, photosensitizers (PSs)
are delivered to target cells or tissues either passively or actively
and are irradiated with a laser. Upon irradiation, the activated
PSs transfer the energy to ground-state oxygen to generate
reactive oxygen species (ROS) that can kill the surrounding
cancer cells.4 The following three criteria must be met for an
efficient PDT: (1) the PS should be highly specific to the targets in
order to diminish the damage to normal tissues; (2) the local
concentration of PS within diseased tissue is high enough toaState Key Laboratory for Physical Chemistry of Solid Surfaces and
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† Electronic supplementary information (ESI) available: The structure of
AlC4Pc, XRD pattern of Fe3O4 nanoparticles, TEM images of Fe3O4@
SiO2(F)@meso-SiO2(P) with different amounts of TEOS, DLS and
dispersion stability of Fe3O4@SiO2(F)@meso-SiO2(P) and Fe3O4@
SiO2(F)@meso-SiO2(P)-Folate nanoparticles in water and other buffers,
Fluorescence spectra of Fe3O4@SiO2(F)@meso-SiO2(P) under 488 nm
excitation after different periods of irradiation with a 660 nm laser beam,
The viability of human hepatocyte cells incubated with Fe3O4@SiO2(F)
@meso-SiO2(P) at different concentrations, the zeta-potential of Fe3O4@
SiO2(F)@meso-SiO2(P) and Fe3O4@SiO2(F)@meso-SiO2(P)-Folate
nanoparticles at different pH, Optical imagings of HeLa cells stained with
Trypan blue after different treatment. The FT-IR spectra of Fe3O4@
SiO2(F)@meso-SiO2(P) and Fe3O4@SiO2(F)@meso-SiO2(P)-Folate. See
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11244 | J. Mater. Chem., 2011, 21, 11244–11252produce adequate singlet oxygen; and (3) there is adequate
oxygen permeability/perfusion in the region of disease, which
directly correlates to the subsequent photo-oxidation reaction
efficiency.5 To achieve a high PDT efficacy, the ability of PS to
enter cells is critical. To date, various carriers, including oil
dispersions, liposomes, low-density lipoproteins, polymeric
micelles, gold nanoparticles, semiconductor quantum dots, iron
oxide nanoparticles and silica nanoparticles, have been demon-
strated with effective delivery of PSs.6–20 These colloidal carriers
not only display enhanced PSs loading capability and improve
the reactivity of PSs, but can also be tailored to the appropriate
size for a localized accumulation at the tumor site due to the
‘‘enhanced permeability and retention effect’’.2,21 Furthermore,
their surfaces can be modified with special targeting moieties
such as antibodies, folate and aptamers for site-specific
behavior.17 Among the various delivery vehicles, mesoporous
silica nanoparticles (MSNs) hold the promise to be a highly
efficient PDT drug delivery platform owing to their attractive
features such as uniform pore size, large surface area and high
accessible pore volume, ease of chemical modification, excellent
biocompatibility and avid uptake by cells.22–26 The porous
structure of MSNs not only permits the accommodation of
a large quantity of PSs, but also helps to enhance the perme-
ability of oxygen and generate singlet oxygen, which is essential
for PDT. However, the reports on the applications of MSNs as
PSs vehicles are rare.27–30
Moreover, the accurate localization of PS-containing nano-
particles in cells or target tissues is very important for effective





























































View Onlineirradiation of target diseased tissues without causing damage to
the healthy tissues.31 Recently, optical imaging probes have been
incorporated into MSNs along with PSs to offer dual capability
of imaging and therapy.28–30 Optical imaging can provide the
highest sensitivity and obtain detailed information at subcellular
levels,32 which allow accurate targeting and simultaneous pho-
totherapy treatment. However, optical imaging still lacks the full
capability to obtain anatomic and physiological details in vivo.
Compared to optical imaging, magnetic resonance imaging
(MRI) offers an excellent spatial resolution and depth for in vivo
imaging, which can provide an anatomic reference. However,
MRI suffers from limited sensitivity and lacks resolution for
imaging at the cellular level.33 A combination of optical imaging
and MRI leads to the development of bimodal imaging probes
that can provide the high sensitivity and resolution of fluores-
cence imaging, as well as the noninvasive and real-time moni-
toring abilities of magnetic resonance imaging, allowing accurate
following the distribution of PSs in vivo and monitoring the
therapeutic efficiency of photodynamic therapy (PDT).
However, the application of multifunctional MSNs as photo-
sensitizing vehicles that provides both MR and fluorescence
imaging diagnosis and photodynamic therapy has not been
satisfied explored.
Herein, we report a facile strategy to fabricate discrete,
monodisperse and size-controllable core-shell nanoparticles
integrating the capabilities of MR imaging, fluorescent imaging,
cancer cell-specific delivery and photodynamic therapy. While
the core of the nanoparticles consists of a single Fe3O4 nano-
particle encapsulated in fluorescent dyes co-doped nonporous
silica, their shell is made from ordered mesoporous silica con-
taining PSs. The nanoparticles are further surface-functionalized
by folic acid to gain the targeting capacity. Fluorescein iso-
thiocyanate (FITC) was chosen as the fluorescence imaging agent
to be covalently incorporated into the silica core which can
isolate the dyes from the external environment and thus protect
the dyes from photobleaching. The photosensitizer molecules of
tetra-substituted carboxyl aluminum phthalocyanine (AlC4Pc,
Figure S1, ESI†) were covalently linked to the mesoporous silica.
In the case of being physically entrapped inside the silica
network, the PS can be prematurely released from the carrier
vehicles while in systemic circulation, leading to a reduced effi-
ciency of PDT treatment.34 The covalent coupling of photosen-
sitizer molecules in the rigid porous structure in our core-shell
carriers helps to obviate the degradation of PS in harsh biological
environments, and overcome their premature release. Further-
more, the mesoporous structure of the shell permits the easy
diffusion of O2 to interact with the PS molecules for ROS
generation. Together with the MRI and fluorescence imaging
capabilities of these nanoparticles in living cells, we have also
evaluated their PDT potential in the treatment of cancer cells.2. Experimental
2.1. Chemicals
Oleic acid, oleylamine, benzyl alcohol, tetraethoxysilane (TEOS),
3-aminopropyltriethoxysilane (APTES) and ethyl-[3-(dimethy-
lamino)propyl]-carbodiimide hydrochloride (EDC) were
purchased from Aldrich Chemical Co. Iron(III) acetylacetonateThis journal is ª The Royal Society of Chemistry 2011(Fe(acac)3) was obtained from Strem Chemical Inc. Brij 56 were
purchased from Alfa Aesar. Human hepatoma cells (QGY-
7703), human hepatocytes (QSG-7701) and HeLa cells were
purchased from cell storeroom of Chinese Academy of Science.
RPMI 1640 cell culture medium, bovine serum albumin (BSA)
and Penicillin-Streptomycin compound were purchased from
Hyclone Laboratories Inc. 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT), Fluorescein
isothiocyanate (FITC), 1,3-diphenylisobenzofuran (DPBF) and
N-hydroxysuccinimide (NHS) were purchased from Sigma.
Tetra-substituted carboxyl aluminum phthalocyanine (AlC4Pc)
was synthesized and purified according to a method in the
literature.35 The water used in all experiments was ultrapure. All
other chemicals were of analytical-reagent grade and used
without further purification.
2.2. Synthesis of Fe3O4 nanoparticles
The magnetic particles were prepared through a solvothermal
reaction.36 Briefly, 0.353 g of Fe(acac)3, 1.5 mL oleic acid and
1.5 mL oleylamine were added to 10.0 mL of benzyl alcohol
under magnetic stirring. The obtained homogeneous yellow
solution was transferred to a Teflon-lined stainless-steel auto-
clave and sealed to heat at 180 C. After reacting for 10 h, the
autoclave was cooled to room temperature. The obtained black
magnetite particles were washed with ethanol three times, and
then redispersed into 9.0 mL cyclohexane for further use.
2.3. Synthesis of Fe3O4@SiO2 or Fe3O4@SiO2(F)
nanoparticles
The nonporous silica layer was coated on the Fe3O4 nano-
particles by a reverse micelle method. 2 mg of FITC was reacted
with 15 mL of APTES in 1.0 mL of ethanol under dark conditions
for 24 h. The prepared FITC–APTES stock solution was kept at
4 C. In a typical procedure, 1.4 g of Brij56, 0.75 mL of the above
cyclohexane solution of Fe3O4 nanoparticles, 0.075 mL H2O and
0.28 mL concentrated ammonia were added to 5.625 mL cyclo-
hexane. After stirring for 30 min, 0.75 mL of TEOS, or 0.5 mL of
FITC–APTES and 0.75 mL of TEOS were added. The reaction
mixture was further stirred for 8 h at 50 C in a water bath in the
dark. The particles were separated and washed with ethanol for
a few times. The obtained Fe3O4@SiO2 or Fe3O4@SiO2(F)
magnetic nanoparticles were stored for further use.
2.4. Synthesis of Fe3O4@SiO2@meso-SiO2(P) and
Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles
Mesoporous silica was further coated onto the Fe3O4@SiO2 or
Fe3O4@SiO2(F). The photosensitizer AlC4Pc–APTES conjugate
was prepared in advance. In a flask, 2 mg of AlC4Pc and 10 mL of
APTES were mixed in 1 mL of DMSO. Next, 3.0 mg of EDC and
2.0 mg of NHS were added into the mixture and stirred for 24 h
at room temperature. The obtained solution was directly used
without further treatment. The Fe3O4@SiO2@meso-SiO2(P) or
Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles were prepared by
a modified St€ober sol–gel process.37 Typically, 0.2 g Fe3O4@SiO2
or Fe3O4@SiO2(F) nanoparticles, 0.17 g CTAB, 0.5 mL
concentrated ammonia and 25 mL ethanol were added to 54 mL





























































View OnlineAlC4Pc–APTES solution and 0.3 mL of TEOS were added. The
reaction mixture was further stirred for 8 h at room temperature.
The particles were separated and washed twice with ethanol.
Finally, the nanospheres were redispersed in 60 mL of acetone
and refluxed at 80 C for 24 h to remove the template CTAB. The
extraction was repeated twice, and the nanospheres were then
centrifuged and washed with ethanol. The amount of bound
AlC4Pc was determined indirectly by the difference between the
amount of AlC4Pc introduced into the sol–gel reaction and the
amount of AlC4Pc in the washing solutions through UV-Vis
spectroscopy; the amount of AlC4Pc conjugated into the
mesoporous silica was about 0.51 wt%.
2.5. Surface modification of the Fe3O4@SiO2(F)@meso-
SiO2(P) nanoparticles with folic acid
To attach folic acid to the Fe3O4@SiO2(F)@meso-SiO2(P), the
folate–APTES conjugate was prepared in advance. 1 mg of folic
acid and 5 mL of APTES were mixed in 1 mL of DMSO which
contains 30mgofNHSand50mgofEDCand stirred for 2 h.Then,
the folate–APTES conjugate was added to a flask containing 4 mL
of toluene and 1 mL of Fe3O4@SiO2(F)@meso-SiO2(P) solution
(20 mg nanoparticles suspended in 1 mL DMSO) and stirred for
20 h at room temperature. The nanoparticles were then centrifuged
and washed with toluene, and dispersed in ethanol.
2.6. Detection of singlet oxygen (1O2)
The singlet oxygen (1O2) generation capabilities of the
Fe3O4@SiO2@meso-SiO2(P), Fe3O4@SiO2(F)@meso-SiO2(P)
and free AlC4Pc were determined by a chemical method, using
1,3-diphenylisobenzofuran (DPBF) as a singlet oxygen sensor.38
DPBF reacts irreversibly with 1O2 which causes a decrease in the
DPBF absorption at 400 nm. In a typical experiment, 50 mL
of DPBF (1.5 mg mL1 in acetonitrile) was added into 2 mL of
1.5 mg mL1 nanoparticles solution in acetonitrile, while the
control used DPBF only in acetonitrile and free AlC4Pc with
DPBF in acetonitrile. The solutions were then irradiated with
a 660 nm laser source, and their optical densities at 400 nm were
recorded at 0, 5, 10, 15, 20, 25, 30, 36, 41, 60, 80, 100, 120 s,
respectively, using the DU-7400 spectrophotometer.
2.7. Fluorescence imaging and magnetic resonance imaging
(MRI)
Human hepatoma cells (QGY-7703), human hepatocytes
(QSG-7701) were cultured in RPMI 1640 medium supplemented
with 10% calf serum, 100 U mL1 penicillin and 100 mg mL1
streptomycin in 37 C, 5% CO2. The cellular uptake of the
nanoparticles was confirmed by fluorescence microscopy. The
cells were plated in a 24 well-plate (Nunc ) with a density of
 0.5  104 cells per well. After incubation in fresh medium for
24 h, cells were incubated with 0.5 mL of the medium containing
200 mg mL1 nanoparticles for 8 h. The cell medium was
removed, and the cells were washed three times with 0.5 mL PBS
to remove the nanoparticles that did not enter the cells. The green
fluorescence emission in cells was detected under the fluorescence
microscopy. For the experiments to observe the MR
contrast effect of the nanoparticles within the cells, human
hepatoma cells (QGY-7703) were incubated with either the11246 | J. Mater. Chem., 2011, 21, 11244–11252Fe3O4@SiO2(F)@meso-SiO2(P) or plain mesoporous silica
nanoparticles under similar conditions as mentioned above. The
adherent cells were detached from the plate by treatment with
trypsin-EDTA and placed in 0.5 mL cell medium for MR
imaging. Each tube contained approximately 105 cells.
2.8. Cell viability assay
The in vitro cytotoxicity was measured by using theMTT assay in
human hepatocytes. Cells were initially seeded into a 96-well cell-
culture plate (Nunc ) at 104 per well and then incubated for
24 h at 37 C under 5% CO2. RPMI 1640 solutions of nano-
particles (0.2 mL per well) at concentrations of 0, 50, 100, 200,
400, 800 mg mL1 were added to the wells. The cells were further
incubated for 24 h at 37 C under 5% CO2. The cells were washed
three times with 0.2 mL PBS to remove the unbound nano-
particles. Subsequently, 0.2 mL RPMI 1640 and 25 mL MTT
(5 mg mL1) were added to each well and incubated for an
additional 4 h at 37 C under 5% CO2. Then the medium solution
was replaced by 0.15 mL dimethylsulfoxide (DMSO) solution.
After 10 min, the optical density at 490 nm (absorption value) of
each well was measured on a Tecan Infinite M 200 mono-
chromator-based multifunction microplate reader. The corre-
sponding nanoparticles with cells but not treated by MTT were
used as controls. The cells vitality after labeling was compared
with that of unlabeled cells and expressed as the relative ratio.
2.9. Photodynamic effect of the nanoparticles on human
hepatoma cells
For MTT assay, human hepatoma cells were seeded in a 96-well
plate at a density of 104 cells per well for 24 h. Then RPMI
1640 cell medium containing different concentrations of
Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles were added to the
wells (0.2 mL per well, 0, 50, 100, 200, 400, 800 mg mL1). After
incubation for 14 h, the cells were washed three times with
0.2 mL PBS to remove the unbound nanoparticles. Then 0.2 mL
PBS was added and the cells were exposed to a 660 nm laser with
a power density of 75 mW cm2 for 5 min. The cell viability was
measured by MTT assay mentioned above and expressed as
a percentage of the control.
For optical imaging, human hepatoma cells were seeded in
a 24-well plate at a density of 105 cells per well for 24 h. Then the
medium was replaced by cell medium containing 200 mg mL1 of
Fe3O4@SiO2(F)@meso-SiO2(P) (0.5 mL per well). After incu-
bation for 14 h, the cells were washed three times with 0.5 mL
PBS to remove the unbound nanoparticles. Then 0.5 mL PBS
was added and the cells were exposed to a 660 nm laser with
a power density of 75 mW cm2 for 2.5 and 10 min, respectively.
After trypan blue staining, the optical imaging was performed by
fluorescence microscopy.
2.10. Targeting of HeLa cells by Fe3O4@SiO2(F)@meso-
SiO2(P)-Folate nanoparticles
HeLa cells were cultured in RPMI 1640 medium supplemented
with 10% calf serum, 100 U mL1 penicillin and 100 mg mL1
streptomycin in 37 C, 5% CO2. To study the cellular uptake of
Fe3O4@SiO2(F)@meso-SiO2(P)-Folate, HeLa cells were seeded
in 35 mm dishes at a density of about 5  104 cells per dish inThis journal is ª The Royal Society of Chemistry 2011






























































View OnlineRPMI-1640. After incubation for 24 h, the culture medium was
replaced by the same medium containing 200 mg mL1
Fe3O4@SiO2(F)@meso- SiO2(P)-Folate nanoparticles or
Fe3O4@SiO2(F)@meso- SiO2(P). After incubation for 8 h, the
cell medium was removed, and the cells were washed three times
with 1.0 mL PBS. The cells were then stained with DAPI solution
before being monitored using an Olympus Fluoriew 1000 laser-
scanning microscope. For flow cytometry analysis, HeLa cells
were plated in 24 well-plate with a density of 5  104 cells per
well. After incubation in the fresh RPMI 1640 medium for 24 h,
cells were incubated with 0.5 mL of the medium containing
200 mg mL1 Fe3O4@SiO2(F)@meso-SiO2(P)-Folate nano-
particles for 8 h. The cell medium was removed, and the cells
were washed three times with 0.5 mL PBS buffer solution. The
adherent cells were detached from the plate by treatment with
trypsin-EDTA, washed and then suspended in 0.5 mL PBS
buffer solution for flow cytometry. For MTT assay of the PDT
effects on HeLa cells, the procedure was similar to that described
previously.
2.11. Characterization
The size and morphologies of nanoparticles were determined at
300 kV using a TECNAI F-30 high-resolution transmission
electron microscopy. Powder X-ray diffraction (XRD)
measurements were taken with a Rigaku D/Max rC X-ray
diffractometer with a rotating target. Magnetic characterization
of Fe3O4 nanoparticles was performed by a superconducting
quantum interference device (Magnetic Property Measurement
System XL-7, Quantum Design). Fluorescence spectra were
recorded with a Hitachi F-4500 fluorescence spectrofluorimeter.
UV-Visible absorption spectra were measured using a Beckman
DU-7400 ultraviolet-visible diode array spectrophotometer. A
MRL-III-660 laser (100 mW, Changchun New Industries
Optoelectronics Tech. Co. Ltd.) was used as the irradiation
source. Dynamic light scattering (DLS) and zeta potential
experiments were carried out on a Nano-ZS (Malvern Instru-
ments). Fluorescence imaging was performed on a Nikon eclipse
Ti-U fluorescence microscope with a C-FL Epi-Fl Filter Block
FITC consisting of excitation filter Ex 465–495, dichroic mirror
DM 505, and barrier filter BA 515–555. Confocal fluorescence
imaging of cells was performed with an Olympus Fluoriew 1000
laser-scanning microscope. Excitation of FITC was carried out
with an Ar laser at l ¼ 488 nm, and emissions were collected in
the range l ¼ 505–600 nm. DAPI was excited by a 405 nm laser
and the emissions were collected in the range l ¼ 420–480 nm.
MRI experiments were performed on a Varian 7.0-TMR system.
An extremity coil was used for the data acquisition, and the pulse
sequence used was a T2-weighted turbo spin-echo sequence with
the following parameters: TR¼ 3000 ms, slice thickness¼ 2 mm,
TE ¼ 70 ms, field of view ¼ 45  45 mm, number of
acquisitions ¼ 1. Flow cytometry (Becton Dickinson).
3. Results and discussion
3.1. Synthesis and characteristics of the multifunctional
nanoparticles
The multifunctional core-shell nanoparticles were prepared by
a multistep process (Scheme 1) (see Experimental section forThis journal is ª The Royal Society of Chemistry 2011details). In brief, monodisperse superparamagnetic Fe3O4
nanoparticles were first prepared using the modified sol-
vothermal method.36 The prepared Fe3O4 nanoparticles were
then coated with a layer of nonporous silica to form
Fe3O4@silica spheres (denoted as Fe3O4@SiO2) via a reverse
micelle method. To covalently incorporate FITC into the
Fe3O4@SiO2 particles, FITC was treated with 3-amino-
propyltriethoxysilane (APTES) and then co-hydrolyzed with
tetraethyl orthosilicate (TEOS) during the reverse micelle
encapsulation process to yield the fluorescent Fe3O4@SiO2(F)
particles. After being separated and cleaned, the Fe3O4@SiO2(F)
particles were dispersed in ethanol for the subsequent coating of
a mesoporous silica layer. The coating of such a mesoporous
SiO2 was achieved by base-catalyzed hydrolysis of TEOS in the
presence of cetyltrimethylammonium bromide (CTAB).37 To
covalently bind the photosensitizer molecules (AlC4Pc) in the
mesoporous silica layer, AlC4Pc was treated with APTES in
advance to form an APTES-AlC4Pc conjugate. The conjugate
was then supplied together with TEOS during the coating
process. The resultant core-shell composite was designated as
Fe3O4@SiO2(F)@meso-SiO2(P). An acetone extraction treat-
ment was then applied to remove the surfactant from the mes-
oporous shell of the composite. Finally, the targeting ligands,
folic acid, which can recognize the over-expressed a-folate
receptor in many cancer cells, were covalently anchored on the
surface of Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles to
produce Fe3O4@SiO2(F)@meso-SiO2(P)-Folate particles.
As shown in Fig. 1a, the prepared monodisperse hydrophobic
Fe3O4 nanoparticles have an average size of 6 nm. In the X-ray
diffraction (XRD) pattern, the main peaks match well with the
standard PDF data of magnetite Fe3O4 (JCPDS No. 01-089-
0691) (Figure S2, ESI†). Using the reverse micelle system of
Brij56-water-cyclohexane, Fe3O4 were successfully encapsulated
within SiO2 in a one-in-one fashion (Fig. 1b). The prepared
Fe3O4@SiO2 nanoparticles had a uniform diameter of 40 
5 nm. As illustrated in the TEM image (Fig. 1c), a uniform layer
of mesoporous silica with a thickness of  9 nm was coated onto
the Fe3O4@SiO2(F) by hydrolysis of TEOS in the presence of
CTAB. The thickness of the mesoporous silica shell is tunable by
varying the amount of TEOS (Figure S3, ESI†). After template
removal, the mesoporous feature in the core-shell composite wasJ. Mater. Chem., 2011, 21, 11244–11252 | 11247
Fig. 1 TEMimagesofa)Fe3O4, b)Fe3O4@SiO2(F) andc)Fe3O4@SiO2(F)
@meso-SiO2(P). d)N2 adsorption/desorption isotherms (77K) andpore size
distribution (inset) of Fe3O4@SiO2(F)@meso-SiO2(P).
Fig. 2 a) Field-dependent magnetization at 300 K. b) T2 relaxivity plot of
an aqueous suspension of Fe3O4@SiO2(F)@meso-SiO2(P) measured at
7.0T, the slope indicates theT2 relaxivity coefficient (r2). c) T2-weightedMR
images of human hepatoma cells that were treated with Fe3O4@SiO2(F)
@meso-SiO2(P) at different concentrations appeared dark compared to the
other samples, (1) RPMImedium; (2) plainmesoporous silica nanoparticles
(800 mg mL1), and Fe3O4@SiO2(F)@meso-SiO2(P) at (3) 50, (4) 100, (5)
200, (6) 400 and (7) 800 mgmL1. d) Fluorescence image showing the uptake





























































View Onlineconfirmed by the N2 adsorption/desorption measurements
(Fig. 1d). The Brunauer–Emmett–Teller (BET) surface area and
the total pore volume of the Fe3O4@SiO2(F)@meso-SiO2(P)
composite were measured to be 455 m2 g1 and 0.99 cm3 g1,
respectively. The Brunauer–Joyner–Halenda (BJH) pore-size
distribution indicates that the Fe3O4@SiO2(F)@meso-SiO2(P)
nanoparticles have uniform mesopores with an average pore size
of 2.5 nm. The overall small particle size (about 50 nm) and the
uniform mesoporous pore holes give these nanoparticles the
potential for imaging and photodynamic therapy applications.3.2. Cancer cells imaging using the multifunctional
nanoparticles
Superparamagnetic nanoparticles are often used as contrasting
agents in MRI. The magnetic measurement of the
Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles at 300 K displays
no hysteresis (Fig. 2a), indicating that they are super-
paramagnetic and favorable for T2 MR contrast agents.
38 The T2
relaxivity (r2, the efficiency of a contrast agent) of the
Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles was determined to
be 194.66 mM1 S1 (The Fe content of the Fe3O4@SiO2(F)
@meso-SiO2(P) was determined by inductively coupled plasma-
atomic emission spectroscopy (ICP-AES)) (Fig. 2b). In order to
evaluate the contrast effect of these nanoparticles inside the cells,
human hepatoma cells (QGY-7703) were first incubated with
different concentrations of nanoparticles for 8 h before being
washed and re-collected in 0.5 mL RPMI cell medium in 0.6 mL
centrifuge tubes. The untreated cells and the cells treated with
plain mesoporous silica nanoparticles (without the magnetite)
were used as controls. As shown in Fig. 2c, the tubes
containing the control samples are fairly bright, whereas the
brightness of the tubes containing the cells treated with the11248 | J. Mater. Chem., 2011, 21, 11244–11252Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles was reduced as the
concentration of the nanoparticles was increased because of the
decrease in T2 relaxation. These results indicate that
the Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles can be used as
MR contrast agents in vitro.
For fluorescence imaging, FITC was incorporated covalently
into the nonporous inner layer silica walls of the Fe3O4@SiO2(F)
@meso-SiO2(P) nanoparticles using a co-condensation method
in the preparation process. The introduction of fluorescence
functionality made it possible to directly monitor the cellular
uptake of the nanoparticles by fluorescence microscopy. After
QGY-7703 cells were incubated with the nanoparticles for 8 h,
the unbound nanoparticles were washed away and the living cells
were imaged using a fluorescence microscope. As shown in
Fig. 2d, the fluorescence from the nanoparticles was readily
observed within the cells. In comparison, under similar imaging
conditions the control cells incubated without the nanoparticles
showed no fluorescence.3.3. Photosensitizers loading and singlet oxygen generation
With FITC in the solid SiO2 core and AlC4Pc covalently bound
in the mesoporous silica shell, as shown in Fig. 3a, the prepared
Fe3O4@SiO2(F)@meso-SiO2(P) particles display the adsorption
features of both FITC and AlC4Pc. Besides an obvious absorp-
tion of FITC at 480 nm, both Soret and Q-band absorptions of
AlC4Pc at 350 and 685 nm, respectively, were observed in
Fe3O4@SiO2(F)@meso-SiO2(P). The presence of the Soret andThis journal is ª The Royal Society of Chemistry 2011
Fig. 3 a) Absorption spectra of Fe3O4@SiO2(F)@meso-SiO2(P),
Fe3O4@SiO2@meso-SiO2(P), Fe3O4@SiO2@meso-SiO2 and free AlC4Pc.
b) Emission spectra of Fe3O4@SiO2(F)@meso-SiO2(P) under excitation
wavelength at 488 and 620 nm, respectively. c) Fe3O4@SiO2@meso-
SiO2(P) were dispersed in DI water, PBS buffer and RPMI 1640 cell
culture medium, respectively, for 10 days. The nanoparticles were then
centrifuged down and UV-Vis absorption spectra of the supernatants
were measured. d) Absorption spectra of Fe3O4@SiO2(F)@meso-SiO2(P)
dispersed in RPMI 1640 cell medium for different times of irradiation
with a 660 nm laser source (75 mW cm2).
Fig. 4 a) Absorption spectra of Fe3O4@SiO2@meso-SiO2(P) in the
presence of DPBF after different times of irradiation with a 660 nm
laser source. The concentration of Fe3O4@SiO2@meso-SiO2(P) is
1.5 mg mL1. Inset: Decay curves of absorption of DPBF at 400 nm as
a function of irradiation time in the presence (Trace 2) and absence
(Trace 1) of Fe3O4@SiO2@meso-SiO2(P). b) Time-dependent photo-
oxidation of DPBF caused by single oxygen generated in acetonitrile by
using Fe3O4@SiO2@meso-SiO2(P) and the same amount of AlC4Pc in
homogeneous solution. The concentrations for loading AlC4Pc and free





























































View OnlineQ-band absorptions features similar to free AlC4Pc molecules
suggested the absence of heavy aggregation of AlC4Pc molecules
in both Fe3O4@SiO2@meso-SiO2(P) and Fe3O4@SiO2(F)
@meso-SiO2(P) particles. In order to investigate the possible
influence of FITC on the optical properties of the photosensi-
tizer, the fluorescence emission spectra of Fe3O4@SiO2(F)
@meso-SiO2(P) dispersed in water were recorded using various
excitation wavelengths. When excited at 488 nm (the absorption
of FITC), the nanoparticles exhibited only one emission peak at
520 nm corresponding to that from fluorescein. When the exci-
tation was changed to 620 nm, the emission spectrum was
dominated by the emission of AlC4Pc with a peak at 695 nm
(Fig. 3b). Under excitation of different wavelengths,
Fe3O4@SiO2(F)@meso-SiO2(P) display different emission
spectra, suggesting that these nanoparticles could be used for
both imaging and photodynamic therapy by switching the
wavelength to allow the light absorption by either FITC or
AlC4Pc. Our photosensitization experiments were performed at
660 nm to ensure that the light was absorbed only by AlC4Pc for
the photosensitization process.
Before photosensitization studies, the leakage of AlC4Pc from
the nanoparticles were investigated by soaking the nanoparticles
in deionized (DI) water, phosphate-buffered saline (PBS) solu-
tion and RPMI 1640 cell culture medium, respectively, for ten
days. After centrifuging, the supernatants were subjected to UV-
Vis adsorption measurements. As illustrated in Fig. 3c, noThis journal is ª The Royal Society of Chemistry 2011detectable dye leakage from the nanoparticles was observed after
ten days of incubation in all three solutions, suggesting that
Fe3O4@SiO2@meso-SiO2(P) nanoparticles are very stable
against dye leaching. The Fe3O4@SiO2(F)@meso-SiO2(P)
nanoparticles also demonstrated good dispersion stability in
water, PBS and cell medium (Figure S4, ESI†), respectively. The
effective hydrodynamic diameter measured by dynamic light
scattering (DLS) was about 56 nm (Figure S4b, ESI†), con-
firming that Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles are
well-dispersed in water. When the nanoparticles were stored in
water and PBS for a week (Figure S4c, ESI†), or 10 h in cell
medium (Figure S4d, ESI†), no significant decrease of absorp-
tion intensity was observed. In addition, the photobleaching tests
of the Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles were also
performed (Fig. 3d). After the nanoparticles were dispersed in
RPMI 1640 cell medium, the nanoparticle solutions were irra-
diated by a 660 nm laser (75 mW cm2) for 15 and 30 min,
respectively. The experimental results indicated that the
absorption spectra of the nanoparticle solution didn’t show any
obvious change after 15 and 30 min irradiation. This further
suggests that our Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles
are very stable against photobleaching. All these will help with
the long-term studies in which nanoparticles need to be moni-
tored over days or even longer.
The PDT-induced cytotoxicity of type II PS is attributed to the
generation of singlet oxygen (1O2).
33 As a potential second-
generation PS displaying strong absorption in the red visible
region, AlC4Pc has a good selectivity for tumors targets and
enhanced PDT-induced cytotoxic efficiency due to its high effi-
ciency of singlet-oxygen photogeneration.39,40 To investigate the
effectiveness of Fe3O4@SiO2@meso-SiO2(P) in generating
1O2
upon light irradiation, we used its reaction with 1,3-diphenyli-
sobenzofuran (DPBF) as an indicator. The reaction results in
the absorption decrease of DPBF at 400 nm.41 Fig. 4a shows
the absorption spectra of DPBF in the presence of
Fe3O4@SiO2@meso-SiO2(P) nanoparticles after different times
of irradiation with a 660 nm laser source at 75 mW cm2. AsJ. Mater. Chem., 2011, 21, 11244–11252 | 11249
Fig. 5 The cytotoxicity of different concentrations of Fe3O4@SiO2(F)
@meso-SiO2(P) on hepatoma cells with 5 min light exposure and without
light irradiation. The concentrations of AlC4Pc were 3.4  107, 6.8 





























































View Onlineillustrated in the inset of Fig. 4a, while no obvious absorption
decrease was observed in the absence of Fe3O4@SiO2@meso-
SiO2(P), the absorption at 400 nm continuously decreased with
the irradiation time in the presence of Fe3O4@SiO2@meso-
SiO2(P). The steep decrease of DPBF absorption implies the
continuous generation of 1O2 by irradiated Fe3O4@SiO2@meso-
SiO2(P). It is worth noting that the AlC4Pc-incorporated
Fe3O4@SiO2@meso-SiO2(P) particles exhibited much higher
activity in photo-oxidation DPBF than the same amount of free
AlC4Pc in solution (Fig. 4b). The enhanced activity by
Fe3O4@SiO2@meso-SiO2(P) suggests that the mesoporous silica
nanovehicle acts not only as a carrier for the photosensitizers but
also as a nanoreactor to facilitate the photo-oxidation reaction,
consistent with previous observations.29 Even with the co-pres-
ence of FITC and AlC4Pc, Fe3O4@SiO2(F)@meso-SiO2(P)
exhibits the capability of 1O2 generation similar to that of
Fe3O4@SiO2@meso-SiO2(P) nanoparticles. More importantly,
the fluorescence spectra of the doped FITC molecules were not
affected during the 1O2 photogeneration process (Figure S5,
ESI†), suggesting that FITC molecules were well protected in the
nonporous silica core and therefore not photo-oxidized by the
generated 1O2 during the photosensitization process. Without
doubt, the solid core-mesoporous shell feature of the prepared
Fe3O4@SiO2(F)@meso-SiO2(P) represents an ideal nano-
structure to integrate PDT drugs together with imaging agents.Fig. 6 Optical imaging of hepatoma cells stained with Trypan blue after
different treatments: a) without nanoparticles and 10 min light exposure
with 75 mW cm2; b) 200 mg mL1 Fe3O4@SiO2(F)@meso-SiO2(P) and
2.5 min light exposure with 75 mW cm2; c) 200 mg mL1 Fe3O4@SiO2(F)
@meso-SiO2(P) and 10 min light exposure with 75 mW cm
2.3.4. Laser-induced in vitro PDT effect on cancer cells
Before in vitro PDT studies in cells, we examined the biocom-
patibility of the Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles.
The relative cell viabilities of human hepatocyte cells (QSG-7701)
after 24 h incubation with different concentrations of nano-
particles were measured by the MTT assay. When the concen-
tration of Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles was up
to 800 mg mL1, the cell viability was still kept at more than 60%
(Figure S6, ESI†), indicating that these nanoparticles are highly
biocompatible. To investigate the PDT efficiency of
Fe3O4@SiO2(F)@meso-SiO2(P), human hepatoma cells (QGY-
7703) were first incubated with different concentrations of
Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles for 14 h and then
treated with or without laser (660 nm) irradiation. The MTT
assay was used to assess the cell viabilities. After 5 min of
continuous laser irradiation at 75 mW cm2, the viability of
QGY-7703 incubated with 200 mg mL1 nanoparticles was 28 
2%, significantly lower than those without irradiation (84  4%)
(Fig. 5). This result indicated that light plays a key role in killing
tumor cells in vitro. When the concentration of Fe3O4@SiO2(F)
@meso-SiO2(P) nanoparticles was increased beyond 200 mg
mL1, the increment of photo-induced cytotoxicity in QGY-7703
slightly increased. However, the dark cytotoxicity of
Fe3O4@SiO2(F)@meso-SiO2(P) in QGY-7703 was also further
increased. We have therefore selected 200 mg mL1 as the
concentration of Fe3O4@SiO2(F)@meso-SiO2(P) for the time-
dependent studies of the photo-induced cytotoxicity. After 14 h
incubation with the nanoparticles, the cells were irradiated with
a 660 nm laser (75 mW cm2) for 2.5 min and 10 min, respec-
tively. The dead cells were then stained with trypan blue,
a vitality dye that only stains the cell when the membrane is
damaged. Microscopic images of QGY-7703 after different11250 | J. Mater. Chem., 2011, 21, 11244–11252treatments are shown in Fig. 6. While only some of the cells died
after 2.5 min irradiation, all cells were killed after 10 min irra-
diation. In comparison, the cells subjected to laser irradiation in
the absence of nanoparticles were kept intact.3.5. Targeting delivery of PSs to cancer cells
The ability to target nanoparticles to specific organelles or
receptors is one of the most important factors for their
prospective application in bioimaging and drug delivery. Various
types of targeting agents, such as antibodies, aptamers and folic
acid, have been developed for the specific identification antigens
or receptors on targeting cancer cells. In this study, folic acid was
modified onto the Fe3O4@SiO2(F)@meso-SiO2(P) as the target-
ing component because folate receptors (FR) are overexpressed
in many human cancerous cells.42 After folate modification, the
nanoparticles still displayed good dispersion in water and other
buffers (Figure S4, ESI†). As shown in Figure S4b, ESI†, the size
distribution of the Fe3O4@SiO2(F)@meso-SiO2(P)-Folate
nanoparticles is about 59 nm, which was close to that ofThis journal is ª The Royal Society of Chemistry 2011
Fig. 8 a) Flow cytometry profiles of HeLa cells after being incubated
with Fe3O4@SiO2(F)@meso-SiO2(P) and Fe3O4@SiO2(F)@meso-
SiO2(P)-Folate for 8 h. Untreated HeLa cells were used as the control. 1,
HeLa cells; 2, HeLa cells + Fe3O4@SiO2(F)@meso-SiO2(P); 3, HeLa cells
+ Fe3O4@SiO2(F)@meso-SiO2(P)-Folate. The concentration of nano-
particles was 200 mg mL1. b) MTT assay to demonstrate the phototoxic
effect of the nanoparticles. HeLa cells were treated with Fe3O4@SiO2(F)
@meso-SiO2(P) and Fe3O4@SiO2(F)@meso-SiO2(P)-Folate for 8 h, then
irradiated with 660 nm laser for 5 min. The untreated cells with the same
light irradiation were used as the control. The concentration of nano-





























































View OnlineFe3O4@SiO2(F)@meso-SiO2(P) particles without the folate
modification. In addition, the zeta potential (Figure S7, ESI†) of
the Fe3O4@SiO2(F)@meso-SiO2(P)-Folate at PBS buffer
(0.1 mol L1, pH 7.4) was about 8.98 mV, more negatively
charged than that of Fe3O4@SiO2(F)@meso-SiO2(P) nano-
particles (3.08 mV).
To evaluate the targeting recognition capability of
Fe3O4@SiO2(F)@meso-SiO2(P)-Folate nanoparticles, human
cervical carcinoma cell line HeLa was incubated with
Fe3O4@SiO2(F)@meso-SiO2(P)-Folate nanoparticles for 8 h in
PBS buffer. For comparison, HeLa cells were also incubated
with Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles under other-
wise identical conditions. After washing the cells with PBS to
remove the unbound nanoparticles, the cellular-uptake charac-
teristics were investigated by laser-scanning confocal microscopy
and flow cytometry (excitation at l ¼ 488 nm for FITC). As
shown in Fig. 7, although the cellular uptake of both nano-
particles was observed by the HeLa cells, the cells incubated with
Fe3O4@SiO2(F)@meso-SiO2(P)-Folate (Fig. 7a, d) displayed
stronger luminescence signals than the cells treated with
Fe3O4@SiO2(F)@meso-SiO2(P) (Fig. 7e, h), suggesting that
more folate-modified nanoparticles were uptaken by HeLa cells.
In addition, flow cytometry analysis results also indicated that
the cells incubated with Fe3O4@SiO2(F)@meso-SiO2(P)-Folate
displayed high emission intensities (line 3 in Fig. 8a), whereas the
emission intensities of HeLa cells treated with Fe3O4@SiO2(F)
@meso-SiO2(P) were lower (line 2 in Fig. 8a). This observation
can be explained by the high specific interaction between folic
acid on the Fe3O4@SiO2(F)@meso-SiO2(P)-Folate and FR on
HeLa cells, which may increase the uptake through folate
receptor-mediated endocytosis.43 Therefore, these results present
strong evidence about the target effects of the Fe3O4@SiO2(F)
@meso-SiO2(P)-Folate nanocomposites for HeLa cells.
Furthermore, the PDT effects of Fe3O4@SiO2(F)@meso-
SiO2(P)-Folate and Fe3O4@SiO2(F)@meso-SiO2(P) nano-
particles on HeLa cells were compared. As shown in Fig. 8b,
although the PDT effects were observed for both nanoparticles,
folate-modified Fe3O4@SiO2(F)@meso-SiO2(P)-Folate nano-
particles killed the HeLa cells more effectively than
Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles. After 5 minFig. 7 Confocal fluorescence images showing the effect of folic acid
modification on the nanoparticles (green fluorescence). The cell nuclei
were stained with DAPI (blue fluorescence). HeLa treated with (A)
Fe3O4@SiO2(F)@meso-SiO2(P)-Folate and (B) Fe3O4@SiO2(F)@meso-
SiO2(P). The concentration of nanoparticles is 200 mg mL
1. a) and e):
nanoparticle fluorescence images, b) and f): DAPI fluorescence images, c)
and g): bright- field images, d): merging of a), b) and c), h): merging of e),
f) and g).
This journal is ª The Royal Society of Chemistry 2011irradiation of the 660 nm laser (75 mW cm2), 60  2.2% of the
HeLa cells treated with the folate-modified nanoparticles were
killed. In comparison, under the same conditions, only 30 3.6%
of the cells treated with Fe3O4@SiO2(F)@meso-SiO2(P) nano-
particles were killed. Fluorescence microscopic experiments
(Figure S8, ESI†) also indicated that after 10 min irradiation,
folate-modified Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles
killed the HeLa cells more effectively (nearly 100%) than
Fe3O4@SiO2(F)@meso-SiO2(P) nanoparticles (nearly 50%),
suggesting the specific targeting capability of folic acid.4. Conclusions
In summary, multifunctional core-shell structured mesoporous
silica nanoparticles with dual imaging and photosensitization
capabilities were successfully fabricated. The encapsulation of
a single magnetite nanoparticle and fluorescence dyes in one
nonporous silica core endows the nanoparticles with the MRI
and fluorescence imaging capabilities, allowing non-invasive
tracking and monitoring of the nanoparticles within cells and
even the body. The photosensitizer molecules (AlC4Pc) cova-
lently bound to the mesoporous silica shell exhibit a good
stability against leaching and an excellent efficiency in photo-
generating of reactive oxygen species. Furthermore, the surface
modification of the core-shell nanoparticles by folic acid allows
the targeted delivery of the PS to cancer cells and therefore
minimizes the toxicity to the surrounding normal tissues. We
have demonstrated the bioapplications of the multifunctional
core-shell nanoparticles for MR and fluorescence imaging, and
photodynamic therapy. In vitro studies indicated that these
nanoparticles effectively killed cancer cells through the PDT
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